InMed Pharmaceuticals (INM) Q3 2023 Earnings

14NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-4.25
-3.03
-1.82
-0.6

Details

Expected EPS
N/A
Actual EPS
-0.76
Surprise EPS
-0.76
Surprise Percent
+∞%

Description

InMed Pharmaceuticals (INM) has reported earnings of -0.76 per share for Q3 2023.

0 Comments

Share your thoughts